BackVcanbio Cell & Gene Engineering , Ltd Overview
Vcanbio Cell & Gene Engineering Corp., Ltd

Vcanbio Cell & Gene Engineering , Ltd PEG Ratio

Valuation check: 600645.SS's PEG ratio is 317.49, above the Healthcare sector average of 11.77.

Get informed when a big investor buys or sells

+ Follow

PEG Ratio

317.49

PEG Ratio

317.49

The PEG ratio measures a stock's valuation relative to its earnings growth rate. A PEG ratio below 1.0 may indicate that the stock is undervalued relative to its growth potential.

PEG Ratio (Comparison Companies)

Loading

PEG Ratio History

Loading

PEG Ratio Comparison

Loading

Vcanbio Cell & Gene Engineering , Ltd (600645.SS) FAQ

As of the most recent data, 600645.SS shows a PEG ratio of 317.49. That is above the Healthcare sector average of 11.77. Scroll down for historical charts and peer comparison views.

The Healthcare sector average PEG ratio is about 11.77. Vcanbio Cell & Gene Engineering , Ltd is at 317.49, which is higher that average. That is roughly 2596.9% above the sector mean. Use the comparison chart on this page to see how 600645.SS stacks up against individual peers as well.

Investors watch 600645.SS's PEG ratio because it compresses price and fundamentals into one number that is easy to compare across companies and over time. Vcanbio Cell & Gene Engineering , Ltd's latest reading is 317.49. Combining that with growth, ROE, and debt metrics usually beats relying on a single multiple.

Besides this peg ratio page, Stockcircle has Vcanbio Cell & Gene Engineering , Ltd's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect PEG ratio (currently 317.49) with ownership activity and broader fundamentals.

The Healthcare average PEG ratio is about 11.77, while 600645.SS is at 317.49. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.